Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenograstim mobilization of bone marrow stem cells in complex anal fistulas and perianal inflammatory bowel disease
2005-004590-24Phase 2Active
- Sponsor
- AOU Città della Salute e della Scienza di Torino
- Start
- Jun 2006
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lenograstim in anal fistula and inflammatory bowel disease (IBD), sponsored by AOU Città della Salute e della Scienza di Torino. Primary endpoints: Stem cell mobilization feasibility, Peripheral hematopoietic stem cell increase and granulation and 1 more. Started Jun 2006; status: active.
02
Drugs
lenograstim
03
Conditions
anal fistulainflammatory bowel disease (IBD)
Beyond the preview
Go deeper on 2005-004590-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004590-24.